Mycenax, SPERA PHARMA Form Alliance to Streamline ADC Manufacturing
Mycenax Biotech has formed a strategic alliance with Japan’s SPERA PHARMA to provide an integrated end-to-end development and manufacturing platform for antibody-drug conjugates (ADCs) and bioconjugates.
Takeda Pharmaceutical Company | 15/09/2025 | By Mrinmoy Dey
Takeda Names Julie Kim as Future CEO Amid Strategic Growth Plans
The appointment follows a multi-year succession process, and Kim will also be proposed as a candidate for election to the Board at Takeda’s Annual General Shareholders Meeting in June 2026.
Takeda Pharmaceutical Company | 05/02/2025 | By Aishwarya | 413
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy